The U.S. Supreme Court this morning ruled, 5-4, that pharmaceutical representatives are “outside salesmen” under the Fair Labor Standards Act. In plain English, this now means that those representatives are now considered exempt from overtime.
This decision is a big victory for pharmaceutical companies who have been
Earlier today, the Second Circuit vacated a lower federal court decision that had dismissed a class action lawsuit by 2500 pharmaceutical representatives who claimed that they were improperly classified as exempt from overtime. The decision paves the way for the class action to continue, and sets the stage for potentially other class actions against other